secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2026-07-10T20:02:58+00:00
Accession:  0001104659-26-082649
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma files prospectus supplement for up to $5.575M ATM offering
-----------------------------------------------------------------------

- Company may sell up to $5,575,709 in common stock under ATM agreement with Citizens JMP Securities.
- Offering uses 'baby shelf' limitation under Form S-3; shelf registration declared effective July 9, 2026.
- Original ATM agreement from March 2025 allowed up to $50M; this supplement caps current sales at baby shelf amount.
- Prospectus supplement dated July 10, 2026 filed pursuant to Rule 424(b).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465926082649/0001104659-26-082649-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465926082649/tm2618293d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-082649

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer